Ep-1268 Two Different Calendula Creams for the Prophylactic Management of Acute Skin Toxicity: A Pilot Prospective Study

MASCC clinical practice guidelines for the prevention and management of acute radiation dermatitis: part 1) systematic review

“…Insufficient evidence was reported to support the use of urea, Xonrid, hydroactive colloid gel, and other interventions. 21 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 Growth factors and oral agents 9 (7) 1721 (78; 40-1142) Enzyme mixture (3); Other (6) Head and neck (5); Breast (2); Multiple (1); Cervical (1) ...…”

“…Natural and miscellaneous agents were assessed in 51 studies, of which 39 were RCTs 21 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 ( Appendix C, Table 5 ). The majority of interventions showed minimal or no benefit protecting against ARD in a randomized setting, including honey-based products, 125 , 126 vitamins, 129 , 130 chamomile-based cream, 141 calendula (marigold)-based products, 113 , 116 and products containing glutamine.…”